Dr Reddys Laboratories Q1 net up 52.49% at Rs 550.39 crore

Image
Press Trust of India New Delhi
Last Updated : Jul 30 2014 | 3:02 PM IST
Pharma major Dr Reddys Laboratories today reported 52.49 per cent jump in net profit at Rs 550.39 crore for the quarter ended June 30, 2014.
It had posted a net profit of Rs 360.93 crore for the April-June quarter of the 2013-14 fiscal, Dr Reddy's said in a filing to the BSE.
Net sales of the company in Q1, 2014-15, rose to Rs 3,517.54 crore, up 23.64 per cent from Rs 2,844.92 crore in the year-ago period.
The company said selling, general and administrative expenses rose to Rs 1,067.89 crore in the quarter under review from Rs 879.36 crore in the year-ago period.
The research and development expenses also rose to Rs 387.53 crore for the quarter, from Rs 242.97 crore in Q1, 2013-14.
Shares of Dr Reddy's were trading at Rs 2,824.90 apiece on the afternoon trade, up 2.10 per cent from its previous close on the BSE.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 30 2014 | 3:02 PM IST

Next Story